Management of chronic hepatitis C in childhood: The impact of therapy in the clinical practice during the first 2 decades

Digestive and Liver Disease

Volumn 43, Issue 4, 2011, Pages 325-329

  Bortolotti, Flavia ^a   Indolfi, Giuseppe ^b   Zancan, Lucia ^a   Giacchino, Raffaella ^c   Verucchi, Gabriella ^d   Cammà, Calogero ^e   Barbera, Cristiana ^f   Resti, Massimo ^b   Marazzi, Maria Grazia ^c   Guido, Maria ^a  

^a UNIVERSITY OF PADOVA   (Italy)

^b UNIVERSITY OF FLORENCE   (Italy)

^c G GASLINI INSTITUTE   (Italy)

^d UNIVERSITY OF BOLOGNA   (Italy)

^e UNIVERSITY OF PALERMO   (Italy)

^f UNIVERSITY OF TURIN   (Italy)

Author keywords

Children; Hepatitis C virus; Natural history; Sustained virological response; Treatment

Indexed keywords

ALANINE AMINOTRANSFERASE; ALBUMIN; INTERFERON; PEGINTERFERON; RECOMBINANT INTERFERON; RIBAVIRIN; VIRUS RNA;

ADOLESCENT; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ALBUMIN BLOOD LEVEL; ARTICLE; CHILD; CHILDHOOD; CLINICAL PRACTICE; COMBINATION CHEMOTHERAPY; CONTROLLED STUDY; DRUG WITHDRAWAL; FEBRILE CONVULSION; FEMALE; FOLLOW UP; GENOTYPE; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; LEUKOPENIA; MAJOR CLINICAL STUDY; MALE; META ANALYSIS; MONOTHERAPY; PRESCHOOL CHILD; PRIORITY JOURNAL; PROTEINURIA; PROTHROMBIN TIME; RETROSPECTIVE STUDY; SCHOOL CHILD; TREATMENT RESPONSE; VIRAL CLEARANCE; VIREMIA;

ADOLESCENT; ANTIVIRAL AGENTS; CHILD; CHILD, PRESCHOOL; DRUG THERAPY, COMBINATION; FEMALE; GENOTYPE; HEPACIVIRUS; HEPATITIS C, CHRONIC; HUMANS; INFANT; INTERFERON ALFA-2B; INTERFERONS; MALE; POLYETHYLENE GLYCOLS; RETROSPECTIVE STUDIES; RIBAVIRIN; RNA, VIRAL;

EID: 79952191247     PISSN: 15908658     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.dld.2010.10.008     Document Type: Article

References (29)

1. Bortolotti F., Jara P., Diaz C., et al. Posttransfusion and community-acquired hepatitis C in childhood. J Pediatr Gastroenterol Nutr 1994, 18:279-283.
2. Jara P., Resti M., Hierro L., et al. Chronic hepatitis C virus infection in childhood: clinical patterns and evolution in 241 Caucasian children. Clin Infect Dis 2003, 36:275-280.
3. Iorio R., Giannattasio A., Sepe A., et al. Chronic hepatitis C in childhood: a 18 year experience. Clin Infect Dis 2005, 41:1431-1437.
4. Bortolotti F., Verucchi G., Cammà C., et al. Long-term course of chronic hepatitis C in children: from viral clearance to end-stage liver disease. Gastroenterology 2008, 134:1900-1907.
5. Bortolotti F., Resti M., Marcellini M., et al. Hepatitis C virus (HCV) genotypes in 373 Italian children with HCV infection: changing distribution and correlation with clinical features and outcome. Gut 2005, 54:852-857.
6. Barshes N.R., Udell I.W., Lee T.C., et al. The natural history of hepatitis C virus in pediatric liver transplant recipients. Liver Transplant 2006, 12:1119-1123.
7. Rumbo C., Fawaz L.R., Emre S.H., et al. Hepatitis C in children: a quaternary referral center perspective. J Pediatr Gastroenterol Nutr 2006, 43:209-216.
8. Guido M., Bortolotti F., Leandro G., et al. Fibrosis in chronic hepatitis C acquired in infancy: is it only a matter of time?. Am J Gastroenterol 2003, 98:660-663.
9. Mohan P., Colvin C., Glymph C., et al. Clinical spectrum and histopathologic features of chronic hepatitis C infection in children. J Pediatr 2007, 150:168-174.
10. Goodman Z.D., Makhlouf H.R., Liu L., et al. Pathology of chronic hepatitis C in children: liver biopsy findings in the Ped-C Trial. Hepatology 2008, 47:836-843.
11. Bortolotti F., Giacchino R., Vajro P., et al. Recombinant interferon alfa therapy in children with chronic hepatitis C. Hepatology 1995, 22:1623-1626.
12. Jacobson K.R., Murray K., Zellos A., Schwarz K.B. An analysis of published trials of Interferon monotherapy in children with chronic hepatitis C. J Pediatr Gastroenterol Nutr 2002, 34:52-58.
13. Bortolotti F., Jorio R., Nebbia G., et al. Interferon treatment in children with chronic hepatitis C: long-lasting remission in responders, and risk for disease progression in non-responders. Digest Liver Dis 2005, 37:336-341.
14. Wirth S., Lang T., Gehring S., et al. Recombinant alfa interferon plus ribavirin therapy in children and adolescents with chronic hepatitis C. Hepatology 2002, 36:1280-1284.
15. Gonzales-Peralta R.P., Kelly D.A., Haber B., et al. Interferon alfa 2b in combination with ribavirin for the treatment of chronic hepatitis C in children: efficacy, safety, and pharmacokinetics. Hepatology 2005, 42:1010-1018.
16. Schwarz K.B., Gonzales Peralta R., Murray K.F., et al. Peginterferon with and without ribavirin for chronic hepatitis C in children and adolescents: final results of PEDS-C trial. Hepatology 2008, 48:418A.
17. Jara P., Hierro L., De la Vega A., et al. Efficacy and safety of PEG-IFN alfa-2b and ribavirin combination therapy in children with chronic hepatitis C. Pediatr Infect Dis J 2008, 27:142-148.
18. Wirth S., Ribes Koninckx C., Calzado M.A., et al. High sustained virologic response rates in children with chronic hepatitis C receiving peginterferon alfa-2b plus ribavirin. J Hepatol 2010, 52:501-507.
19. Jara P., Hierro L. Treatment of hepatitis C in children. Expert Rev Gastroenterol Hepatol 2010, 4:51-61.
20. Bortolotti F., Iorio R., Resti M., et al. An epidemiological survey of hepatitis C virus infection in Italian children in the decade 1990-1999. J Pediatr Gastroenterol Nutr 2001, 32:562-566.
21. Bortolotti F., Iorio R., Resti M., et al. Epidemiological profile of 806 Italian children with hepatitis C virus infection over a 15-year period. J Hepatol 2007, 46:783-790.
22. Bortolotti F., Muratori I., Jara P., et al. Hepatitis C virus infection associated with liver-kidney microsomal antibody type 1 (LKM1) autoantibodies in children. J Pediatr 2003, 142:185-190.
23. Ishak K., Baptista A., Bianchi L., et al. Histological grading and staging of chronic hepatitis. J Hepatol 1995, 22:666-669.
24. Romanò L., Azara A., Chiaramonte M., et al. Low prevalence of anti-HCV antibody among Italian children. Infection 1994, 22:350-352.
25. Indolfi G., Resti A. Perinatal transmission of hepatitis C virus. J Med Virol 2008, 80:1907-1911.
26. Jhaveri R., Grant W., Kauf T.L., et al. The burden of hepatitis C virus infection in children: estimated direct medical costs over a 10-year period. J Pediatr 2006, 148:353-358.
27. Karnsakul W., Alford M.K., Schwarz K.B. Managing pediatric hepatitis C: current and emerging treatment options. Ther Clin Risk Manag 2009, 5:651-660.
28. Ledinghen V., Le Bail B., Rebouissoux L., et al. Liver stiffness measurement in children using fibroscan: feasibility study and comparison with fibrotest, aspartate transaminase to platelets ratio index, and liver biopsy. J Pediatr Gastroenterol Nutr 2007, 45:443-450.
29. Ghany M.G., Strader D.B., Thomas D.L., et al. Diagnosis, management, and treatment of hepatitis C: an update. Hepatology 2009, 49:1335-1374.